(Q41585099)

4 October 2017

1 reference

title

Rationale for early intervention in acute stroke (English)

1 reference

4 October 2017

G W Albers

1

1 reference

PubMed ID

9284038

4 October 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

American Journal of Cardiology

4 October 2017

1 reference

4 October 2017

80

1 reference

4 October 2017

4D-10D; discussion 35D-39D

1 reference

4 October 2017

4C

1 reference

Viability thresholds and the penumbra of focal ischemia

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900579-1

Tissue plasminogen activator for acute ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900579-1

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900579-1

Thrombolytic therapy with streptokinase in acute ischemic stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900579-1

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900579-1

Pathophysiology of acute ischaemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900579-1

Clinical experience with excitatory amino acid antagonist drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900579-1

Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900579-1

In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900579-1

Glycine site NMDA receptor antagonists provide protection against ischemia-induced neuronal damage in hippocampal slice cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900579-1

Nitric oxide and the cerebral circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900579-1

Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900579-1

10.1016/S0002-9149(97)00579-1

7 January 2021

Identifiers

DOI

1 reference

4 October 2017

1 reference

PubMed ID

9284038